Search Results - Oppermann, C.P.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    PCN38 Health-Related Quality of Life (QOL) in Monarch PLUS: A Phase 3 Trial of Abemaciclib PLUS Nonsteroidal Aromatase Inhibitor (NSAI) or Fulvestrant for Women with HR+/HER2- Advanced Breast Cancer (ABC)

    PCN38 Health-Related Quality of Life (QOL) in Monarch PLUS: A Phase 3 Trial of Abemaciclib PLUS Nonsteroidal Aromatase Inhibitor (NSAI) or Fulvestrant for Women with HR+/HER2- Adva... by Hu, X.C., Zhang, Q.Y., Sun, T., Yin, Y.M., Li, H.P., Yan, M., Tong, Z.S., Oppermann, C.P., Liu, Y.P., Han, R.B., Wang, N., Zhang, Y.L., Zhang, W.L., Jiang, Z.F.

    Published in Value in health
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Do chip size limits exist for DCA?

    Do chip size limits exist for DCA? by Schubert, A., Dudek, R., Leutenbauer, R., Doring, R., Kloeser, J., Oppermann, H., Michel, B., Reichl, H., Baldwin, D.F., Jianmin Qu, Sitaraman, S.K., Swaminathan, M., Wong, C.P., Tummala, R.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Do chip size limits exist for DCA?

    Do chip size limits exist for DCA? by Schubert, A., Dudek, R., Leutenbauer, R., Doring, R., Kloeser, J., Oppermann, H., Michel, B., Reichl, H., Baldwin, D., Qu, J., Sitaraman, S., Swaminathan, M., Wong, C.P., Tummala, R.

    Request full text
    Conference Proceeding
    Save to List
    Saved in:

Search Tools: